Reverse Payment Agreement Template for England and Wales

A Reverse Payment Agreement is a specialised legal settlement document that resolves patent disputes between original patent holders and generic manufacturers, primarily in pharmaceutical markets. Under England and Wales law, these agreements involve the patent holder making monetary payments to the generic manufacturer in exchange for delayed market entry, effectively settling patent litigation while managing competitive timing.

When do you need this document?

You need a Reverse Payment Agreement when facing patent litigation with a generic manufacturer challenging your pharmaceutical patent validity or when you're a generic manufacturer seeking to settle patent disputes before costly court proceedings. These agreements are essential when the patent holder prefers to control market entry timing rather than risk losing patent protection in court. They're particularly valuable in pharmaceutical markets where patent expiry timing directly impacts market exclusivity and revenue streams. The document becomes necessary when both parties seek certainty over lengthy litigation outcomes and wish to establish clear market entry dates while maintaining patent holder compensation.

Key legal considerations

Your Reverse Payment Agreement must carefully balance intellectual property protection with competition law compliance under the Competition Act 1998 and Article 101 TFEU. The payment amount and market delay period require justification as legitimate patent settlement rather than anti-competitive market division. You must include provisions demonstrating the agreement's pro-competitive effects, such as guaranteed market entry dates and patent validity acknowledgments. The document should contain robust competition law compliance clauses, including regular review mechanisms and termination triggers if competition concerns arise. Additionally, you need clear definitions of the relevant product markets, patent scope, and territorial limitations to prevent regulatory scrutiny. Payment arrangements must be structured as legitimate settlement compensation rather than exclusion payments that could attract Competition and Markets Authority investigation.

Legal requirements in England and Wales

Under England and Wales law, your Reverse Payment Agreement must comply with the Competition Act 1998's Chapter I prohibitions against anti-competitive agreements and demonstrate objective justification for any market restrictions. The agreement requires detailed patent dispute background documentation and evidence of genuine patent validity concerns to justify settlement terms. You must include provisions for Competition and Markets Authority notification if the agreement meets merger control thresholds or raises competition concerns. The document needs compliance with the Patents Act 1977 regarding patent licensing and settlement arrangements, ensuring proper intellectual property rights acknowledgment. Additionally, your agreement should reference the Enterprise Act 2002's market investigation powers and include mechanisms for regulatory cooperation if authorities request information about the settlement's competitive effects.